FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HARMS, C.
Right arrow Articles by HÖRTNAGL, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HARMS, C.
Right arrow Articles by HÖRTNAGL, H.
(The FASEB Journal. 2000;14:1814-1824.)
© 2000 FASEB

Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures

CHRISTOPH HARMS*, MARION LAUTENSCHLAGER*,{ddagger}, ALEXANDRA BERGK{ddagger}, DORETTE FREYER{ddagger}, MARKUS WEIH{ddagger}, ULRICH DIRNAGL{ddagger}, JOERG R. WEBER{ddagger} and HEIDE HÖRTNAGL*1

* Institute of Pharmacology and Toxicology, Medical Faculty Charité, Humboldt-University Berlin, D-10098 Berlin, Germany; and
{ddagger} Department of Neurology, Medical Faculty Charité, Humboldt-University Berlin, D-10098 Berlin, Germany

1Correspondence: Institute of Pharmacology and Toxicology, Medical Faculty Charité, Dorotheenstr. 94, D-10098 Berlin, Germany. E-mail: heide.hoertnagl{at}charite.de

To assess the neuroprotective potential of melatonin in apoptotic neuronal cell death, we investigated the efficacy of melatonin in serum-free primary neuronal cultures of rat cortex by using three different models of caspase-dependent apoptotic, excitotoxin-independent neurodegeneration and compared it to that in necrotic neuronal damage. Neuronal apoptosis was induced by either staurosporine or the neurotoxin ethylcholine aziridinium (AF64A) with a delayed occurrence of apoptotic cell death (within 72 h). The apoptotic component of oxygen-glucose deprivation (OGD) unmasked by glutamate antagonists served as a third model. As a model for necrotic cell death, OGD was applied. Neuronal injury was quantified by LDH release and loss of metabolic activity. Although melatonin (0.5 mM) partly protected cortical neurons from OGD-induced necrosis, as measured by a significant reduction in LDH release, it was not effective in all three models of apoptotic cell death. In contrast, exaggeration of neuronal damage by melatonin was observed in native cultures as well as after induction of apoptosis. The present data suggest that the neuroprotectiveness of melatonin strongly depends on the model of neuronal cell death applied. As demonstrated in three different models of neuronal apoptosis, the progression of the apoptotic type of neuronal cell death cannot be withhold or is even exaggerated by melatonin, in contrast to its beneficial effect in the necrotic type of cell death.—Harms, C., Lautenschlager, M., Bergk, A., Freyer, D., Weih, M., Dirnagl, U., Weber, J. R., Hörtnagl, H. Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures.


Key Words: ethylcholine aziridinium (AF64A) • staurosporine • oxygen-glucose deprivation • cortex • oxidative stress




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al.
Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids
J. Neurosci., April 25, 2007; 27(17): 4562 - 4571.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
V. N. Anisimov
Effects of Exogenous Melatonin--A Review
Toxicol Pathol, October 1, 2003; 31(6): 589 - 603.
[Abstract] [PDF]


Home page
FASEB J.Home page
T. WALTHER, L. OLAH, C. HARMS, B. MAUL, M. BADER, H. HORTNAGL, H.-P. SCHULTHEISS, and G. MIES
Ischemic injury in experimental stroke depends on angiotensin II
FASEB J, February 1, 2002; 16(2): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Katchanov, C. Harms, K. Gertz, L. Hauck, C. Waeber, L. Hirt, J. Priller, R. von Harsdorf, W. Bruck, H. Hortnagl, et al.
Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death
J. Neurosci., July 15, 2001; 21(14): 5045 - 5053.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Harms, M. Lautenschlager, A. Bergk, J. Katchanov, D. Freyer, K. Kapinya, U. Herwig, D. Megow, U. Dirnagl, J. R. Weber, et al.
Differential Mechanisms of Neuroprotection by 17 {beta}-Estradiol in Apoptotic versus Necrotic Neurodegeneration
J. Neurosci., April 15, 2001; 21(8): 2600 - 2609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The Federation of American Societies for Experimental Biology.